Complete Filing Data
Phathom Pharmaceuticals, Inc. reported Stockholders Equity of -$438.17 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Phathom Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$221.2M | -$334.3M | -$201.6M | -$197.7M | -$143.9M | -$129.1M | -$255.1M | -$1.3M |
| Operating Income Loss | -$160.0M | -$277.5M | -$167.3M | -$172.4M | -$135.1M | -$125.7M | -$106.2M | -$1.2M |
| Operating Expenses | $312.5M | $324.7M | $167.8M | $172.4M | $135.1M | $125.7M | $106.2M | $1.2M |
| Nonoperating Income Expense | -$61.3M | -$56.9M | -$34.3M | -$25.3M | -$8.8M | -$3.4M | -$148.9M | -$63.0K |
| Research And Development Expense | $32.8M | $34.1M | $49.9M | $71.4M | $72.3M | $98.1M | $20.4M | $20.0K |
| Other Nonoperating Income Expense | -$190.0K | -$8.0K | -$188.0K | -$110.0K | -$2.1M | -$8.0K | -$10.0K | |
| General And Administrative Expense | $101.0M | $62.7M | $27.5M | $6.9M | $1.2M | |||
| Interest Expense | $42.0M | $27.3M | $6.8M | $4.6M | $4.2M | $13.0K | ||
| Research And Development Expense Related Party | $760.0K | $2.1M | $4.9M | $2.8M | $1.2M | $0.00 | ||
| General And Administrative Expense Related Party | $0.00 | $18.0K | $157.0K | $312.0K | $321.0K | |||
| Selling General And Administrative Expense | $279.7M | $290.7M | $117.9M | $101.0M | ||||
| Revenues | $175.1M | $55.3M | $682.0K | $0.00 | ||||
| Cost Of Revenue | $22.6M | $8.0M | $167.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$30.0M | -$75.8M | -$94.3M | -$85.6M | -$91.4M | -$82.9M | -$43.2M | -$41.0M | -$37.8M | -$51.1M | -$50.9M | -$40.7M | -$36.7M | -$36.6M | -$34.8M | -$53.7M | -$34.1M | -$21.1M | -$20.1M | -$98.0M | -$68.1M | -$87.8M | -$1.3M | -$484.0K | -$290.0K | -$260.0K | -$254.0K |
| Operating Income Loss | -$15.3M | -$59.9M | -$78.9M | -$70.8M | -$77.3M | -$70.0M | -$35.7M | -$31.7M | -$30.1M | -$42.5M | -$45.4M | -$37.9M | -$33.1M | -$35.3M | -$33.6M | -$52.4M | -$32.8M | -$20.0M | -$20.4M | -$15.7M | -$6.3M | -$83.0M | -$1.2M | -$451.0K | -$268.0K | -$255.0K | -$251.0K |
| Operating Expenses | $58.6M | $94.4M | $103.7M | $84.8M | $83.2M | $71.4M | $35.7M | $31.7M | $30.1M | $42.5M | $45.4M | $37.9M | $33.1M | $35.3M | $33.6M | $52.4M | $32.8M | $20.0M | $20.4M | $15.7M | $6.3M | $83.0M | $1.2M | $451.0K | $268.0K | $255.0K | $251.0K |
| Nonoperating Income Expense | -$14.7M | -$15.9M | -$15.5M | -$14.8M | -$14.1M | -$12.9M | -$7.6M | -$9.3M | -$7.7M | -$8.6M | -$5.6M | -$2.8M | -$3.5M | -$1.2M | -$1.3M | -$1.3M | -$1.3M | -$1.1M | $234.0K | -$82.3M | -$61.8M | -$4.7M | -$25.0K | -$33.0K | -$22.0K | -$5.0K | -$3.0K |
| Research And Development Expense | $7.0M | $9.1M | $9.2M | $8.7M | $7.4M | $9.4M | $12.3M | $12.8M | $11.5M | $19.0M | $18.8M | $17.7M | $16.6M | $21.6M | $20.6M | $41.7M | $25.8M | $14.9M | $15.9M | $12.7M | $4.5M | $2.8M | $429.0K | $14.0K | $6.0K | ||
| Other Nonoperating Income Expense | -$7.0K | -$155.0K | -$22.0K | -$8.0K | -$6.0K | -$43.0K | -$197.0K | $3.0K | $20.0K | -$11.0K | -$2.0K | -$7.0K | -$2.0M | $10.0K | -$1.0K | -$4.0K | -$1.0K | -$7.0K | |||||||||
| General And Administrative Expense | $23.4M | $18.9M | $18.6M | $23.5M | $26.5M | $20.2M | $16.5M | $13.7M | $13.0M | $10.8M | $7.1M | $5.2M | $4.5M | $3.0M | $1.8M | $1.3M | $797.0K | $437.0K | $262.0K | $255.0K | $251.0K | ||||||
| Interest Expense | $17.8M | $17.2M | $10.1M | $9.6M | $9.2M | $9.3M | $5.7M | $2.8M | $1.5M | $1.3M | $1.3M | $1.3M | $1.3M | $738.0K | $2.0M | $1.1M | $11.0K | $4.0K | |||||||||
| Research And Development Expense Related Party | $679.0K | $130.0K | $233.0K | $175.0K | $77.0K | $370.0K | $1.4M | $849.0K | $905.0K | $939.0K | $1.0M | $249.0K | $404.0K | $207.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| General And Administrative Expense Related Party | $14.0K | $14.0K | $3.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $16.0K | $62.0K | $34.0K | $43.0K | $156.0K | $47.0K | -$29.0K | $72.0K | |||||||||||
| Selling General And Administrative Expense | $51.6M | $85.3M | $94.5M | $76.1M | $75.9M | $62.0M | $23.4M | $18.9M | $18.6M | ||||||||||||||||||
| Revenues | $49.5M | $39.5M | $28.5M | $16.4M | $7.3M | $1.9M | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Cost Of Revenue | $6.2M | $5.0M | $3.7M | $2.4M | $1.4M | $426.0K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$438.2M | -$253.6M | -$72.8M | -$74.8M | $72.2M | $194.3M | $228.0M | -$1.3M | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $132.8M | $300.1M | $384.3M | $155.9M | $183.4M | $287.5M | $243.8M | $879.0K | |
| Retained Earnings Accumulated Deficit | -$1.48B | -$1.26B | -$928.7M | -$727.1M | -$529.4M | -$385.5M | -$256.4M | -$1.3M | |
| Prepaid Expense And Other Assets Current | $15.4M | $20.9M | $13.2M | $5.1M | $3.3M | $3.9M | $11.8M | $23.0K | |
| Liabilities Current | $132.0M | $85.7M | $38.8M | $26.2M | $18.9M | $55.5M | $3.7M | $2.2M | |
| Liabilities And Stockholders Equity | $259.1M | $378.3M | $413.8M | $164.8M | $189.4M | $295.1M | $257.2M | $902.0K | |
| Liabilities | $697.3M | $631.9M | $486.6M | $239.6M | $117.3M | $100.8M | $29.2M | $2.2M | |
| Interest Payable Current | $1.8M | $1.7M | $1.1M | $854.0K | $477.0K | $312.0K | $156.0K | $13.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$167.3M | -$84.1M | $228.4M | -$27.5M | -$104.1M | $43.7M | $242.9M | $879.0K | |
| Cash And Cash Equivalents At Carrying Value | $130.0M | $297.3M | $381.4M | $155.4M | $183.3M | $287.5M | $243.8M | $879.0K | |
| Assets Current | $229.0M | $360.1M | $397.4M | $160.5M | $186.5M | $291.4M | $255.6M | $902.0K | |
| Assets | $259.1M | $378.3M | $413.8M | $164.8M | $189.4M | $295.1M | $257.2M | $902.0K | |
| Additional Paid In Capital Common Stock | $1.05B | $1.01B | $855.9M | $652.3M | $601.5M | $579.8M | $484.4M | $2.0K | |
| Accrued Liabilities Current | $89.8M | $53.2M | $17.2M | $14.7M | $11.4M | $10.6M | $2.3M | $170.0K | |
| Accounts Payable Current | $5.0M | $10.5M | $12.6M | $10.0M | $5.2M | $16.8M | $699.0K | $55.0K | |
| Property Plant And Equipment Net | $1.1M | $1.5M | $2.1M | $1.2M | $650.0K | $986.0K | $463.0K | ||
| Other Liabilities Noncurrent | $4.0M | $11.5M | $9.7M | $7.5M | $7.5M | $4.1M | $2.1M | ||
| Other Assets Noncurrent | $2.9M | $1.7M | $1.7M | $299.0K | $181.0K | $384.0K | $181.0K | ||
| Operating Lease Right Of Use Asset | $2.6M | $613.0K | $1.5M | $2.3M | $1.9M | $2.4M | $933.0K | ||
| Operating Lease Liability Current | $648.0K | $501.0K | $726.0K | $708.0K | $487.0K | $474.0K | $161.0K | ||
| Common Stock Value | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | ||
| Long Term Debt Noncurrent | $209.1M | $201.4M | $137.8M | $95.3M | $89.7M | $39.6M | $22.8M | ||
| Treasury Stock Common Shares | 19.00 | 19.00 | 19.00 | 19.00 | 1.00 | ||||
| Operating Lease Liability Noncurrent | $2.1M | $0.00 | $462.0K | $1.1M | $1.2M | $1.6M | $635.0K | ||
| Accrued Expenses Related Parties Current | $2.5M | $2.3M | $734.0K | $308.0K | $2.0K | ||||
| Non Cash Settlement Of Employee Stock Purchase Plan Liability In Common Stock | $3.0M | $2.4M | $1.4M | $909.0K | $819.0K | ||||
| Non Cash Settlement Of Defined Contribution Plan Liability In Common Stock | $5.3M | $3.7M | $1.6M | $1.1M | $903.0K | ||||
| Non Cash Final Interest Payment Fee | $0.00 | $1.8M | $2.2M | $0.00 | $7.5M | $2.1M | $2.1M | ||
| Accounts Payable Related Parties Current | $1.3M | $173.0K | $200.0K | $45.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$422.5M | -$405.8M | -$338.4M | -$187.1M | -$233.8M | -$148.5M | -$17.8M | $17.6M | -$90.2M | -$26.4M | -$7.0M | $38.0M | $103.5M | $132.1M | $164.3M | $156.4M | $188.4M | $208.7M | -$152.5M | -$84.4M | -$2.5M | -$802.0K | -$512.0K | -$252.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $138.0M | $152.4M | $215.2M | $337.5M | $279.1M | $325.1M | $216.5M | $249.4M | $130.1M | $197.3M | $207.9M | $138.6M | $224.6M | $209.7M | $238.0M | $226.4M | $247.3M | $256.7M | $74.5M | $82.9M | $72.0K | $131.0K | ||||
| Retained Earnings Accumulated Deficit | -$1.46B | -$1.43B | -$1.36B | -$1.19B | -$1.10B | -$1.01B | -$849.1M | -$805.9M | -$764.9M | -$672.0M | -$621.0M | -$570.0M | -$493.5M | -$456.9M | -$420.3M | -$331.8M | -$297.7M | -$276.6M | -$158.4M | |||||||
| Prepaid Expense And Other Assets Current | $13.2M | $14.6M | $13.1M | $15.0M | $15.5M | $12.7M | $12.9M | $8.8M | $10.3M | $975.0K | $1.9M | $7.7M | $695.0K | $1.7M | $4.8M | $800.0K | $1.4M | $5.2M | $3.2M | |||||||
| Liabilities Current | $93.1M | $91.8M | $74.0M | $65.3M | $47.0M | $43.5M | $24.0M | $21.5M | $14.4M | $22.9M | $21.1M | $11.4M | $27.8M | $39.6M | $40.8M | $27.7M | $13.3M | $4.6M | $207.5M | |||||||
| Liabilities And Stockholders Equity | $240.3M | $250.2M | $294.2M | $387.0M | $319.4M | $356.5M | $237.0M | $265.0M | $144.0M | $201.9M | $213.5M | $149.0M | $228.4M | $214.6M | $246.4M | $230.9M | $252.4M | $263.9M | $79.7M | |||||||
| Liabilities | $662.8M | $656.1M | $632.6M | $574.2M | $553.2M | $505.0M | $254.8M | $247.4M | $234.2M | $228.4M | $220.5M | $111.0M | $124.9M | $82.5M | $82.0M | $74.5M | $64.0M | $55.2M | $232.2M | |||||||
| Interest Payable Current | $1.8M | $1.8M | $1.8M | $1.5M | $1.4M | $1.3M | $957.0K | $927.0K | $911.0K | $686.0K | $565.0K | $481.0K | $214.0K | $302.0K | $312.0K | $302.0K | $302.0K | $237.0K | $2.3M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$84.9M | -$59.2M | -$25.8M | -$44.8M | -$49.5M | $12.9M | -$807.0K | |||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $135.2M | $149.6M | $212.3M | $334.7M | $276.2M | $322.2M | $213.7M | $248.8M | $129.6M | $196.8M | $207.4M | $138.1M | $224.6M | $209.7M | $238.0M | $226.4M | $247.3M | $256.7M | $74.5M | |||||||
| Assets Current | $207.8M | $218.9M | $264.9M | $373.8M | $304.8M | $340.3M | $226.7M | $257.7M | $139.8M | $197.8M | $209.3M | $145.7M | $225.3M | $211.3M | $242.8M | $227.2M | $248.7M | $261.8M | $77.7M | |||||||
| Assets | $240.3M | $250.2M | $294.2M | $387.0M | $319.4M | $356.5M | $237.0M | $265.0M | $144.0M | $201.9M | $213.5M | $149.0M | $228.4M | $214.6M | $246.4M | $230.9M | $252.4M | $263.9M | $79.7M | |||||||
| Additional Paid In Capital Common Stock | $1.04B | $1.03B | $1.02B | $1.00B | $869.1M | $863.0M | $831.3M | $823.5M | $674.7M | $645.6M | $614.0M | $608.1M | $597.0M | $589.0M | $584.7M | $488.2M | $486.1M | $485.3M | $6.0M | |||||||
| Accrued Liabilities Current | $65.3M | $64.3M | $43.0M | $35.8M | $27.3M | $16.5M | $13.5M | $15.5M | $8.0M | $13.3M | $13.8M | $7.6M | $11.0M | $8.8M | $6.6M | $16.6M | $6.3M | $3.0M | $2.1M | |||||||
| Accounts Payable Current | $1.1M | $4.0M | $11.6M | $7.1M | $7.7M | $8.4M | $5.8M | $4.2M | $4.8M | $7.1M | $5.8M | $2.9M | $5.6M | $5.4M | $10.9M | $4.8M | $4.9M | $1.2M | $439.0K | |||||||
| Property Plant And Equipment Net | $1.2M | $1.2M | $1.4M | $1.7M | $1.8M | $2.0M | $2.0M | $1.2M | $1.3M | $831.0K | $883.0K | $708.0K | $692.0K | $803.0K | $907.0K | $862.0K | $748.0K | $768.0K | $40.0K | |||||||
| Other Liabilities Noncurrent | $11.5M | $11.5M | $11.5M | $10.8M | $10.5M | $9.7M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $2.1M | |||||||
| Other Assets Noncurrent | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $3.8M | $3.7M | $299.0K | $805.0K | $805.0K | $805.0K | $341.0K | $291.0K | $385.0K | $381.0K | $381.0K | $381.0K | $2.0M | |||||||
| Operating Lease Right Of Use Asset | $2.7M | $873.0K | $388.0K | $833.0K | $1.1M | $1.3M | $1.7M | $1.9M | $2.1M | $2.5M | $2.6M | $1.8M | $2.0M | $2.1M | $2.3M | $2.5M | $2.6M | $939.0K | ||||||||
| Operating Lease Liability Current | $591.0K | $238.0K | $316.0K | $680.0K | $720.0K | $730.0K | $721.0K | $717.0K | $712.0K | $685.0K | $628.0K | $490.0K | $484.0K | $480.0K | $477.0K | $431.0K | $416.0K | $148.0K | ||||||||
| Common Stock Value | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | ||||||||
| Long Term Debt Noncurrent | $207.1M | $205.1M | $203.2M | $175.7M | $174.4M | $149.0M | $99.3M | $97.8M | $96.6M | $93.9M | $92.4M | $91.0M | $88.3M | $37.3M | $35.6M | $41.1M | $44.9M | |||||||||
| Treasury Stock Common Shares | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | ||||||||||||||
| Operating Lease Liability Noncurrent | $2.1M | $589.0K | $0.00 | $133.0K | $292.0K | $628.0K | $789.0K | $945.0K | $1.2M | $1.4M | $1.1M | $1.3M | $1.4M | $1.5M | $1.6M | $1.7M | $606.0K | |||||||||
| Accrued Expenses Related Parties Current | $3.2M | $2.7M | $2.8M | $2.8M | $2.6M | $2.4M | $2.5M | $872.0K | $1.8M | $1.5M | $1.0M | $415.0K | $185.0K | $177.0K | $176.0K | |||||||||||
| Non Cash Settlement Of Employee Stock Purchase Plan Liability In Common Stock | $1.9M | $770.0K | $856.0K | $515.0K | $358.0K | |||||||||||||||||||||
| Non Cash Settlement Of Defined Contribution Plan Liability In Common Stock | $2.1M | $712.0K | $456.0K | $254.0K | $323.0K | |||||||||||||||||||||
| Non Cash Final Interest Payment Fee | $2.1M | |||||||||||||||||||||||||
| Accounts Payable Related Parties Current | $78.0K | $35.0K | $80.0K | $69.0K | $82.0K | $311.0K | $124.0K | $335.0K | $331.0K | $142.0K | $112.0K | $57.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$166.8M | -$266.8M | -$137.6M | -$146.5M | -$148.5M | -$69.7M | -$36.5M | -$1.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$5.5M | $7.7M | $8.1M | $1.9M | -$605.0K | -$8.0M | $11.8M | $23.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $34.1M | $34.9M | $6.4M | $8.7M | -$9.8M | $24.0M | $2.3M | $225.0K |
| Increase Decrease In Interest Payable Net | $121.0K | $565.0K | $292.0K | $377.0K | $165.0K | $156.0K | $156.0K | $13.0K |
| Share Based Compensation | $28.7M | $24.0M | $45.0M | $24.1M | $16.8M | $5.8M | $406.0K | |
| Net Cash Provided By Used In Investing Activities | -$229.0K | -$135.0K | -$1.6M | -$1.0M | -$328.0K | -$1.0M | -$25.3M | |
| Net Cash Provided By Used In Financing Activities | -$288.0K | $182.8M | $367.6M | $120.0M | $44.7M | $114.5M | $304.6M | $1.9M |
| Payments To Acquire Property Plant And Equipment | $229.0K | $135.0K | $1.6M | $1.0M | $328.0K | $1.0M | $132.0K | |
| Depreciation Depletion And Amortization | $633.0K | $795.0K | $575.0K | $620.0K | $521.0K | $323.0K | $8.0K | |
| Increase Decrease In Operating Right Of Use Asset And Lease Liabilities | $222.0K | $175.0K | $194.0K | -$238.0K | $98.0K | -$205.0K | $51.0K | |
| Increase Decrease In Accounts Payable And Accrued Expenses Related Parties | $184.0K | $1.1M | $2.8M | $399.0K | $460.0K | $47.0K | ||
| Proceeds From Issuance Of Long Term Debt | $0.00 | $59.4M | $39.3M | $0.00 | $96.9M | $25.0M | $24.9M | |
| Increase Decrease In Other Noncurrent Assets | $1.2M | $0.00 | $1.4M | $118.0K | -$203.0K | $203.0K | $181.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$84.9M | -$69.0M | -$39.7M | -$44.8M | -$49.8M | -$11.4M | -$807.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$7.8M | -$447.0K | $5.1M | $4.4M | $965.0K | -$6.7M | $120.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$7.0M | -$5.0M | -$11.3M | -$6.1M | -$9.5M | $1.5M | $539.0K |
| Increase Decrease In Interest Payable Net | $92.0K | $161.0K | $57.0K | $4.0K | $0.00 | $81.0K | $11.0K |
| Share Based Compensation | $5.5M | $5.6M | $7.0M | $5.8M | $3.8M | $563.0K | |
| Net Cash Provided By Used In Investing Activities | -$18.0K | -$40.0K | -$214.0K | -$67.0K | -$169.0K | -$676.0K | |
| Net Cash Provided By Used In Financing Activities | $0.00 | $9.9M | $14.1M | $412.0K | $25.0M | ||
| Payments To Acquire Property Plant And Equipment | $18.0K | $40.0K | $214.0K | $67.0K | $169.0K | $676.0K | |
| Depreciation Depletion And Amortization | $177.0K | $214.0K | $146.0K | $128.0K | $125.0K | $52.0K | |
| Increase Decrease In Operating Right Of Use Asset And Lease Liabilities | $40.0K | $45.0K | $50.0K | $22.0K | $25.0K | -$48.0K | |
| Increase Decrease In Accounts Payable And Accrued Expenses Related Parties | $484.0K | $137.0K | $2.7M | $428.0K | $289.0K | $46.0K | |
| Proceeds From Issuance Of Long Term Debt | $0.00 | $9.9M | $0.00 | $25.0M | |||
| Increase Decrease In Other Noncurrent Assets | $117.0K | $1.0K | $200.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.03 | -$5.29 | -$3.93 | -$5.05 | -$3.89 | -$3.88 | -$22.45 | -$0.21 |
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 71.4M | 68.5M | 58.0M | 41.5M | 30.5M | 28.5M | 24.7M | |
| Common Stock Shares Issued | 71.4M | 68.5M | 68.5M | 41.7M | 31.7M | 31.3M | 29.0M | |
| Weighted Average Number Of Shares Outstanding Basic | 72.9M | 63.2M | 51.3M | 39.1M | 37.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 72.9M | 63.2M | 51.3M | 39.1M | 37.0M | |||
| Earnings Per Share Basic | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.0M | 33.2M | 11.4M | 6.1M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.41 | -$1.05 | -$1.31 | -$1.32 | -$1.56 | -$1.42 | -$0.76 | -$0.84 | -$0.89 | -$1.32 | -$1.33 | -$1.07 | -$0.98 | -$1.00 | -$0.96 | -$1.58 | -$1.02 | -$0.64 | -$0.62 | -$3.97 | -$9.30 | -$13.11 | -$0.19 | -$0.07 | -$0.04 | -$0.04 | -$0.07 |
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 71.0M | 70.1M | 69.6M | 68.3M | 58.6M | 58.5M | 56.8M | 56.6M | 43.6M | 41.1M | 38.4M | 38.1M | 30.0M | 29.2M | 28.9M | 25.9M | 25.6M | 25.2M | 7.4M | 6.8M | |||||||
| Common Stock Shares Issued | 71.0M | 70.1M | 69.6M | 68.3M | 58.6M | 58.5M | 56.8M | 56.6M | 43.6M | 41.6M | 39.1M | 39.1M | 31.4M | 31.3M | 31.3M | 29.0M | 29.0M | 29.0M | 11.9M | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 73.4M | 72.5M | 72.0M | 64.6M | 58.6M | 58.4M | 56.8M | 48.5M | 42.4M | 38.8M | 38.3M | 38.0M | 37.3M | 36.6M | |||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 73.4M | 72.5M | 72.0M | 64.6M | 58.6M | 58.4M | 56.8M | 48.5M | 42.4M | 38.8M | 38.3M | 38.0M | 37.3M | 36.6M | |||||||||||||
| Earnings Per Share Basic | $-0.41 | $-1.05 | $-1.31 | $-1.32 | $-1.56 | $-1.42 | $-0.76 | $-0.84 | $-0.89 | $-1.32 | $-1.33 | $-1.07 | $-0.98 | $-1.00 | |||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.0M | 37.3M | 36.6M | 36.3M | 34.1M | 33.4M | 33.0M | 32.5M | 24.7M | 7.3M | 6.7M | 6.6M | 6.8M | 6.8M | 6.8M | 3.9M | |||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Preferred Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | ||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $28.7M | $24.0M | $45.0M | $24.1M | $16.8M | $5.8M | $406.0K |
| Investment Income Interest | $7.0M | $15.2M | $7.9M | $2.1M | $41.0K | $1.1M | $1.1M |
| Interest Paid Net | $21.4M | $17.3M | $11.1M | $7.0M | $4.1M | $3.5M | $1.0M |
| Defined Contribution Plan Employer Discretionary Match Number Of Shares Settled | 616.4K | 383.6K | 136.0K | 101.5K | 8.4K | ||
| Amortization Of Financing Costs | $3.0M | $2.2M | $1.9M | $2.1M | $3.6M | $1.3M | $409.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $3.0M | $2.4M | $1.4M | $909.0K | $819.0K | ||
| Defined Contribution Plan Employer Discretionary Contribution Amount | $5.3M | $3.7M | $1.6M | $1.1M | $903.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $8.0K | $18.0K | $138.0K | $2.0K | $145.0K | $339.0K |
| Other Noncash Income Expense | -$5.2M | -$5.1M | -$1.9M | -$1.3M | -$823.0K | -$322.0K | |
| Stock Issued During Period Value Stock Options Exercised | $1.6M | $1.6M | $124.0K | $1.9M | $629.0K | ||
| Paid In Kind Interest | $3.8M | $3.6M | $3.5M | $990.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.3M | $8.3M | $5.5M | $5.6M | $6.1M | $5.6M | $6.1M | $7.3M | $7.0M | $5.8M | $5.9M | $5.8M | $4.4M | $4.2M | $3.8M | $2.1M | $828.0K | $563.0K | $36.0K | $29.0K |
| Investment Income Interest | $1.4M | $1.8M | $2.6M | $3.7M | $3.6M | $4.3M | $2.7M | $348.0K | $1.5M | $726.0K | $112.0K | $7.0K | $8.0K | $13.0K | $14.0K | $15.0K | $182.0K | $878.0K | $429.0K | $101.0K |
| Interest Paid Net | $5.2M | $3.7M | $2.5M | $1.4M | $906.0K | $458.0K | ||||||||||||||
| Defined Contribution Plan Employer Discretionary Match Number Of Shares Settled | 290.2K | 93.7K | 83.8K | 52.1K | 84.8K | 16.8K | 18.4K | |||||||||||||
| Amortization Of Financing Costs | $696.0K | $474.0K | $496.0K | $518.0K | $364.0K | $199.0K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.1M | $1.9M | $1.6M | $770.0K | $561.0K | $856.0K | $394.0K | $515.0K | $461.0K | $358.0K | ||||||||||
| Defined Contribution Plan Employer Discretionary Contribution Amount | $3.1M | $2.1M | $3.0M | $712.0K | $1.2M | $456.0K | $862.0K | $254.0K | $580.0K | $323.0K | ||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $44.0K | $7.0K | $0.00 | $120.0K | $21.0K | $20.0K | ||||||||||||||
| Other Noncash Income Expense | -$1.8M | -$1.7M | -$763.0K | -$591.0K | -$357.0K | |||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $293.0K | $80.0K | $282.0K | $21.0K | $13.0K | $111.0K | $1.3M | $104.0K | $412.0K | |||||||||||
| Paid In Kind Interest | $1.1M | $806.0K | $877.0K | $848.0K |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.